Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Chris Schott is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/27/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/24/2025 | AMRX | Buy Now | Amneal Pharmaceuticals | $8.36 | 43.54% | Chris Schott60% | $9 → $12 | Upgrade | Neutral → Overweight | Get Alert |
| 01/29/2025 | GILD | Buy Now | Gilead Sciences | $109.79 | 4.75% | Chris Schott60% | $105 → $115 | Maintains | Overweight | Get Alert |
| 11/13/2024 | ABBV | Buy Now | AbbVie | $201.98 | -0.98% | Chris Schott60% | $210 → $200 | Maintains | Overweight | Get Alert |
| 11/07/2024 | GILD | Buy Now | Gilead Sciences | $109.79 | -4.36% | Chris Schott60% | $100 → $105 | Maintains | Overweight | Get Alert |
| 11/04/2024 | BIIB | Buy Now | Biogen | $142.43 | 47.44% | Chris Schott60% | $220 → $210 | Maintains | Neutral | Get Alert |
| 10/24/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $640.14 | 79.65% | Chris Schott60% | $1200 → $1150 | Maintains | Overweight | Get Alert |
| 10/21/2024 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.62 | 15.24% | Chris Schott60% | $16 → $18 | Maintains | Neutral | Get Alert |
| 10/11/2024 | IDXX | Buy Now | IDEXX Laboratories | $420.00 | 36.9% | Chris Schott60% | $630 → $575 | Maintains | Overweight | Get Alert |
| 10/11/2024 | ZTS | Buy Now | Zoetis | $162.30 | 41.71% | Chris Schott60% | $225 → $230 | Maintains | Overweight | Get Alert |
| 10/09/2024 | GILD | Buy Now | Gilead Sciences | $109.79 | -8.92% | Chris Schott60% | $95 → $100 | Maintains | Overweight | Get Alert |
| 09/13/2024 | LLY | Buy Now | Eli Lilly | $826.50 | 33.09% | Chris Schott60% | $1050 → $1100 | Maintains | Overweight | Get Alert |
| 09/06/2024 | OGN | Buy Now | Organon | $14.80 | 35.14% | Chris Schott60% | $18 → $20 | Downgrade | Neutral → Underweight | Get Alert |
| 09/06/2024 | AMRX | Buy Now | Amneal Pharmaceuticals | $8.36 | 7.66% | Chris Schott60% | → $9 | Upgrade | Underweight → Neutral | Get Alert |
| 08/02/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $640.14 | 87.46% | Chris Schott60% | $1150 → $1200 | Maintains | Overweight | Get Alert |
| 07/25/2024 | ABBV | Buy Now | AbbVie | $201.98 | 3.97% | Chris Schott60% | $190 → $210 | Maintains | Overweight | Get Alert |
| 07/11/2024 | LLY | Buy Now | Eli Lilly and Co | $826.50 | 20.99% | Chris Schott60% | $900 → $1000 | Maintains | Overweight | Get Alert |
| 06/17/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $640.14 | 79.65% | Chris Schott60% | $1050 → $1150 | Maintains | Overweight | Get Alert |
| 05/01/2024 | LLY | Buy Now | Eli Lilly and Co | $826.50 | 8.89% | Chris Schott60% | $850 → $900 | Maintains | Overweight | Get Alert |
| 04/11/2024 | BIIB | Buy Now | Biogen | $142.43 | 68.5% | Chris Schott60% | $270 → $240 | Maintains | Neutral | Get Alert |
| 03/15/2024 | LLY | Buy Now | Eli Lilly and Co | $826.50 | 2.84% | Chris Schott60% | $775 → $850 | Maintains | Overweight | Get Alert |
| 03/08/2024 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.62 | -10.37% | Chris Schott60% | → $14 | Upgrade | Underweight → Neutral | Get Alert |
| 02/28/2024 | PRGO | Buy Now | Perrigo | $26.41 | 55.24% | Chris Schott60% | $48 → $41 | Maintains | Overweight | Get Alert |
| 02/20/2024 | RPRX | Buy Now | Royalty Pharma | $31.50 | 33.33% | Chris Schott60% | $45 → $42 | Maintains | Overweight | Get Alert |
| 02/06/2024 | IDXX | Buy Now | IDEXX Laboratories | $420.00 | 50% | Chris Schott60% | $600 → $630 | Maintains | Overweight | Get Alert |
| 11/08/2023 | LLY | Buy Now | Eli Lilly | $826.50 | — | Chris Schott60% | — | Reiterates | → Overweight | Get Alert |
| 11/02/2023 | IDXX | Buy Now | IDEXX Laboratories | $420.00 | 30.95% | Chris Schott60% | $600 → $550 | Maintains | Overweight | Get Alert |
| 10/20/2023 | AMGN | Buy Now | Amgen | $305.60 | -11.65% | Chris Schott60% | → $270 | Reinstates | Neutral → Neutral | Get Alert |
| 10/16/2023 | PFE | Buy Now | Pfizer | $25.24 | 34.71% | Chris Schott60% | $36 → $34 | Maintains | Neutral | Get Alert |
| 10/06/2023 | PFE | Buy Now | Pfizer | $25.24 | 42.63% | Chris Schott60% | $39 → $36 | Maintains | Neutral | Get Alert |
| 08/09/2023 | PRGO | Buy Now | Perrigo | $26.41 | 81.75% | Chris Schott60% | $45 → $48 | Maintains | Overweight | Get Alert |
| 08/09/2023 | LLY | Buy Now | Eli Lilly | $826.50 | -27.4% | Chris Schott60% | $510 → $600 | Maintains | Overweight | Get Alert |
| 08/02/2023 | IDXX | Buy Now | IDEXX Laboratories | $420.00 | 42.86% | Chris Schott60% | $550 → $600 | Maintains | Overweight | Get Alert |
| 07/28/2023 | LLY | Buy Now | Eli Lilly | $826.50 | -38.29% | Chris Schott60% | $475 → $510 | Maintains | Overweight | Get Alert |
| 05/04/2023 | LLY | Buy Now | Eli Lilly | $826.50 | -42.53% | Chris Schott60% | $430 → $475 | Maintains | Overweight | Get Alert |
| 04/28/2023 | LLY | Buy Now | Eli Lilly | $826.50 | -47.97% | Chris Schott60% | $400 → $430 | Maintains | Overweight | Get Alert |
| 03/31/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $640.14 | 48.41% | Chris Schott60% | $900 → $950 | Maintains | Overweight | Get Alert |
| 02/23/2023 | MRK | Buy Now | Merck & Co | $88.28 | 41.59% | Chris Schott60% | $120 → $125 | Maintains | Overweight | Get Alert |
| 02/07/2023 | IDXX | Buy Now | IDEXX Laboratories | $420.00 | 30.95% | Chris Schott60% | $525 → $550 | Maintains | Overweight | Get Alert |
| 01/20/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $640.14 | 32.78% | Chris Schott60% | → $850 | Upgrade | Neutral → Overweight | Get Alert |
| 11/15/2022 | VTRS | Buy Now | Viatris | $8.99 | 55.73% | Chris Schott60% | $13 → $14 | Maintains | Neutral | Get Alert |
| 11/14/2022 | CHRS | Buy Now | Coherus BioSciences | $0.92 | 1095.65% | Chris Schott60% | $13 → $11 | Maintains | Neutral | Get Alert |
| 11/14/2022 | EQRX | Buy Now | EQRx | — | — | Chris Schott60% | — | Downgrade | Neutral → Underweight | Get Alert |
| 11/14/2022 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.62 | -35.98% | Chris Schott60% | $11 → $10 | Downgrade | Neutral → Underweight | Get Alert |
| 10/18/2022 | RPRX | Buy Now | Royalty Pharma | $31.50 | 65.08% | Chris Schott60% | $50 → $52 | Maintains | Overweight | Get Alert |
| 10/17/2022 | ELAN | Buy Now | Elanco Animal Health | $10.55 | 89.57% | Chris Schott60% | $24 → $20 | Maintains | Neutral | Get Alert |
| 10/17/2022 | HSKA | Buy Now | Heska | — | — | Chris Schott60% | $175 → $150 | Maintains | Overweight | Get Alert |
| 10/17/2022 | ZTS | Buy Now | Zoetis | $162.30 | 38.63% | Chris Schott60% | $250 → $225 | Maintains | Overweight | Get Alert |
| 10/17/2022 | IDXX | Buy Now | IDEXX Laboratories | $420.00 | 7.14% | Chris Schott60% | $525 → $450 | Maintains | Overweight | Get Alert |
| 10/04/2022 | GILD | Buy Now | Gilead Sciences | $109.79 | -27.13% | Chris Schott60% | $72 → $80 | Upgrade | Neutral → Overweight | Get Alert |
| 09/30/2022 | BIIB | Buy Now | Biogen | $142.43 | 93.08% | Chris Schott60% | $221 → $275 | Maintains | Neutral | Get Alert |
| 08/16/2022 | EQRX | Buy Now | EQRx | — | — | Chris Schott60% | → $5.5 | Initiates | → Neutral | Get Alert |
| 08/16/2022 | ELAN | Buy Now | Elanco Animal Health | $10.55 | — | Chris Schott60% | — | Downgrade | Overweight → Neutral | Get Alert |
| 07/29/2022 | BHC | Buy Now | Bausch Health Companies | $6.70 | — | Chris Schott60% | — | Downgrade | Overweight → Neutral | Get Alert |
| 07/18/2022 | ELAN | Buy Now | Elanco Animal Health | $10.55 | 203.32% | Chris Schott60% | $37 → $32 | Maintains | Overweight | Get Alert |
| 06/13/2022 | BHC | Buy Now | Bausch Health Companies | $6.70 | 79.1% | Chris Schott60% | → $12 | Reinstates | → Overweight | Get Alert |
| 06/01/2022 | LLY | Buy Now | Eli Lilly | $826.50 | -57.05% | Chris Schott60% | $340 → $355 | Maintains | Overweight | Get Alert |
| 04/14/2022 | RPRX | Buy Now | Royalty Pharma | $31.50 | 58.73% | Chris Schott60% | → $50 | Upgrade | Neutral → Overweight | Get Alert |
| 03/07/2022 | CHRS | Buy Now | Coherus BioSciences | $0.92 | 1530.43% | Chris Schott60% | → $15 | Downgrade | Overweight → Neutral | Get Alert |
| 02/23/2022 | HSKA | Buy Now | Heska | — | — | Chris Schott60% | $300 → $250 | Maintains | Overweight | Get Alert |
| 01/28/2022 | MRK | Buy Now | Merck & Co | $88.28 | 7.61% | Chris Schott60% | $100 → $95 | Maintains | Overweight | Get Alert |
| 06/15/2021 | OGN | Buy Now | Organon | $14.80 | 156.76% | Chris Schott60% | → $38 | Initiates | → Neutral | Get Alert |
| 06/15/2021 | LLY | Buy Now | Eli Lilly | $826.50 | -68.54% | Chris Schott60% | $240 → $260 | Maintains | Overweight | Get Alert |
| 06/09/2021 | MRK | Buy Now | Merck & Co | $88.28 | 13.28% | Chris Schott60% | $105 → $100 | Maintains | Overweight | Get Alert |
| 03/02/2021 | VTRS | Buy Now | Viatris | $8.99 | 100.22% | Chris Schott60% | → $18 | Downgrade | Overweight → Neutral | Get Alert |
| 01/29/2021 | IDXX | Buy Now | IDEXX Laboratories | $420.00 | 35.71% | Chris Schott60% | → $570 | Initiates | → Overweight | Get Alert |
| 01/29/2021 | HSKA | Buy Now | Heska | — | — | Chris Schott60% | → $195 | Initiates | → Overweight | Get Alert |
| 10/16/2020 | MRK | Buy Now | Merck & Co | $88.28 | 18.94% | Chris Schott60% | $98 → $105 | Maintains | Overweight | Get Alert |
| 10/16/2020 | LLY | Buy Now | Eli Lilly | $826.50 | -75.8% | Chris Schott60% | $190 → $200 | Maintains | Overweight | Get Alert |
| 10/16/2020 | BMY | Buy Now | Bristol-Myers Squibb | $59.21 | 31.73% | Chris Schott60% | $74 → $78 | Maintains | Overweight | Get Alert |
| 09/09/2020 | HZNP | Buy Now | Horizon Therapeutics | — | — | Chris Schott60% | → $110 | Initiates | → Overweight | Get Alert |
| 07/13/2020 | RPRX | Buy Now | Royalty Pharma | $31.50 | 58.73% | Chris Schott60% | → $50 | Initiates | → Neutral | Get Alert |
| 06/17/2020 | LLY | Buy Now | Eli Lilly | $826.50 | -77.01% | Chris Schott60% | $175 → $190 | Maintains | Overweight | Get Alert |
| 06/01/2020 | PFE | Buy Now | Pfizer | $25.24 | 42.63% | Chris Schott60% | $37 → $36 | Maintains | Neutral | Get Alert |
| 05/27/2020 | KALA | Buy Now | Kala Pharmaceuticals | $6.51 | 191.86% | Chris Schott60% | $700 → $950 | Maintains | Overweight | Get Alert |
| 05/19/2020 | MNK | Buy Now | Mallinckrodt | — | — | Chris Schott60% | — | Downgrade | Neutral → Underweight | Get Alert |
| 05/19/2020 | TXMD | Buy Now | TherapeuticsMD | $1.01 | — | Chris Schott60% | — | Downgrade | Overweight → Neutral | Get Alert |
| 03/24/2020 | PRGO | Buy Now | Perrigo | $26.41 | 115.83% | Chris Schott60% | → $57 | Upgrade | Neutral → Overweight | Get Alert |
| 02/06/2020 | CHRS | Buy Now | Coherus BioSciences | $0.92 | 3704.35% | Chris Schott60% | $33 → $35 | Maintains | Overweight | Get Alert |
| 12/18/2019 | LLY | Buy Now | Eli Lilly | $826.50 | -81.85% | Chris Schott60% | $140 → $150 | Maintains | Overweight | Get Alert |
| 12/12/2019 | BHC | Buy Now | Bausch Health Companies | $6.70 | 467.16% | Chris Schott60% | $32 → $38 | Upgrade | Neutral → Overweight | Get Alert |
| 11/12/2019 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.62 | — | Chris Schott60% | — | Upgrade | Underweight → Neutral | Get Alert |
| 11/08/2019 | KALA | Buy Now | Kala Pharmaceuticals | $6.51 | 115.05% | Chris Schott60% | $1100 → $700 | Maintains | Overweight | Get Alert |
| 09/06/2019 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.62 | -55.19% | Chris Schott60% | $9 → $7 | Maintains | Underweight | Get Alert |
| 06/14/2019 | MRK | Buy Now | Merck & Co | $88.28 | 5.35% | Chris Schott60% | $90 → $93 | Maintains | Overweight | Get Alert |
| 05/13/2019 | SNNA | Buy Now | Sienna Biopharmaceuticals | — | — | Chris Schott60% | — | Downgrade | Overweight → Neutral | Get Alert |
| 05/13/2019 | ENDP | Buy Now | Endo International | — | — | Chris Schott60% | → $9 | Downgrade | Neutral → Underweight | Get Alert |
| 05/13/2019 | BHC | Buy Now | Bausch Health Companies | $6.70 | — | Chris Schott60% | — | Upgrade | Underweight → Neutral | Get Alert |
| 05/03/2019 | BMY | Buy Now | Bristol-Myers Squibb | $59.21 | — | Chris Schott60% | — | Reinstates | → Overweight | Get Alert |
| 03/18/2019 | ENDP | Buy Now | Endo International | — | — | Chris Schott60% | $16 → $10 | Maintains | Neutral | Get Alert |
| 12/11/2018 | PFE | Buy Now | Pfizer | $25.24 | 82.25% | Chris Schott60% | → $46 | Downgrade | Overweight → Neutral | Get Alert |
| 11/14/2018 | KALA | Buy Now | Kala Pharmaceuticals | $6.51 | 237.94% | Chris Schott60% | $1750 → $1100 | Maintains | Overweight | Get Alert |
| 11/02/2018 | PCRX | Buy Now | Pacira BioSciences | $24.42 | 104.75% | Chris Schott60% | $45 → $50 | Maintains | Neutral | Get Alert |
| 10/08/2018 | BMY | Buy Now | Bristol-Myers Squibb | $59.21 | 24.98% | Chris Schott60% | $70 → $74 | Maintains | Overweight | Get Alert |
| 09/26/2018 | LLY | Buy Now | Eli Lilly | $826.50 | -85.84% | Chris Schott60% | → $117 | Reinstates | Not Rated → Overweight | Get Alert |
| 08/10/2018 | PRGO | Buy Now | Perrigo | $26.41 | 183.98% | Chris Schott60% | $83 → $75 | Maintains | Neutral | Get Alert |
| 06/15/2018 | TXMD | Buy Now | TherapeuticsMD | $1.01 | 989.11% | Chris Schott60% | → $550 | Initiates | → Overweight | Get Alert |
| 04/10/2018 | PCRX | Buy Now | Pacira BioSciences | $24.42 | 76.09% | Chris Schott60% | $40 → $43 | Maintains | Neutral | Get Alert |
| 03/05/2018 | PRGO | Buy Now | Perrigo | $26.41 | 214.27% | Chris Schott60% | $82 → $83 | Maintains | Neutral | Get Alert |
| 12/18/2017 | PCRX | Buy Now | Pacira BioSciences | $24.42 | 92.47% | Chris Schott60% | → $47 | Initiates | → Neutral | Get Alert |
| 11/13/2017 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.62 | — | Chris Schott60% | — | Downgrade | Neutral → Underweight | Get Alert |
| 08/21/2017 | SNNA | Buy Now | Sienna Biopharmaceuticals | — | — | Chris Schott60% | → $28 | Initiates | → Overweight | Get Alert |
| 08/14/2017 | KALA | Buy Now | Kala Pharmaceuticals | $6.51 | 437.63% | Chris Schott60% | → $1750 | Initiates | → Overweight | Get Alert |
| 01/20/2017 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.62 | — | Chris Schott60% | — | Downgrade | Overweight → Neutral | Get Alert |
| 01/20/2017 | ENDP | Buy Now | Endo International | — | — | Chris Schott60% | — | Downgrade | Overweight → Neutral | Get Alert |
| 11/30/2016 | MNK | Buy Now | Mallinckrodt | — | — | Chris Schott60% | $85 → $78 | Maintains | Neutral | Get Alert |
| 09/08/2016 | LLY | Buy Now | Eli Lilly | $826.50 | -88.51% | Chris Schott60% | $92 → $95 | Maintains | Overweight | Get Alert |
| 09/08/2016 | LLY | Buy Now | Eli Lilly | $826.50 | — | Chris Schott60% | — | Upgrade | Neutral → Overweight | Get Alert |
| 08/11/2016 | PRGO | Buy Now | Perrigo | $26.41 | 240.78% | Chris Schott60% | $105 → $90 | Maintains | Neutral | Get Alert |
| 05/04/2016 | MNK | Buy Now | Mallinckrodt | — | — | Chris Schott60% | $100 → $85 | Maintains | Neutral | Get Alert |
| 04/26/2016 | PRGO | Buy Now | Perrigo | $26.41 | 297.58% | Chris Schott60% | $145 → $105 | Maintains | Neutral | Get Alert |
| 04/07/2016 | PFE | Buy Now | Pfizer | $25.24 | 50.55% | Chris Schott60% | → $38 | Assumes | → Overweight | Get Alert |
| 03/21/2016 | ENDP | Buy Now | Endo International | — | — | Chris Schott60% | $80 → $65 | Maintains | Overweight | Get Alert |
| 09/21/2015 | MRK | Buy Now | Merck & Co | $88.28 | -26.37% | Chris Schott60% | $68 → $65 | Maintains | Overweight | Get Alert |
| 09/21/2015 | LLY | Buy Now | Eli Lilly | $826.50 | -89.11% | Chris Schott60% | $83 → $90 | Maintains | Neutral | Get Alert |
| 08/05/2015 | MNK | Buy Now | Mallinckrodt | — | — | Chris Schott60% | $140 → $120 | Downgrade | Overweight → Neutral | Get Alert |
| 08/03/2015 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.62 | 444.17% | Chris Schott60% | → $85 | Upgrade | Neutral → Overweight | Get Alert |
| 05/21/2015 | ENDP | Buy Now | Endo International | — | — | Chris Schott60% | $105 → $110 | Maintains | Overweight | Get Alert |
| 04/29/2015 | PFE | Buy Now | Pfizer | $25.24 | 50.55% | Chris Schott60% | $36 → $38 | Maintains | Overweight | Get Alert |
| 04/02/2015 | ENDP | Buy Now | Endo International | — | — | Chris Schott60% | → $105 | Assumes | → Overweight | Get Alert |
| 03/17/2015 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.62 | 316.13% | Chris Schott60% | $60 → $65 | Maintains | Neutral | Get Alert |
| 03/05/2015 | BMY | Buy Now | Bristol-Myers Squibb | $59.21 | 26.67% | Chris Schott60% | $70 → $75 | Maintains | Overweight | Get Alert |
| 02/17/2015 | CHRS | Buy Now | Coherus BioSciences | $0.92 | 3704.35% | Chris Schott60% | $20 → $35 | Maintains | Overweight | Get Alert |
| 02/13/2015 | MNK | Buy Now | Mallinckrodt | — | — | Chris Schott60% | $110 → $130 | Upgrade | Neutral → Overweight | Get Alert |
| 02/10/2015 | PFE | Buy Now | Pfizer | $25.24 | 42.63% | Chris Schott60% | $35 → $36 | Maintains | Overweight | Get Alert |
| 02/06/2015 | PRGO | Buy Now | Perrigo | $26.41 | 581.56% | Chris Schott60% | $190 → $180 | Maintains | Overweight | Get Alert |
| 02/02/2015 | LLY | Buy Now | Eli Lilly | $826.50 | -91.05% | Chris Schott60% | $70 → $74 | Maintains | Neutral | Get Alert |
| 11/03/2014 | BMY | Buy Now | Bristol-Myers Squibb | $59.21 | 11.47% | Chris Schott60% | $63 → $66 | Maintains | Overweight | Get Alert |
| 08/08/2014 | MNK | Buy Now | Mallinckrodt | — | — | Chris Schott60% | $96 → $102 | Maintains | Buy | Get Alert |
| 07/28/2014 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.62 | 271.32% | Chris Schott60% | $56 → $58 | Maintains | Neutral | Get Alert |
| 06/10/2014 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.62 | 258.51% | Chris Schott60% | $55 → $56 | Maintains | Neutral | Get Alert |
| 05/28/2014 | PFE | Buy Now | Pfizer | $25.24 | 38.67% | Chris Schott60% | → $35 | Assumes | → Overweight | Get Alert |
| 05/09/2014 | MNK | Buy Now | Mallinckrodt | — | — | Chris Schott60% | $73 → $85 | Maintains | Neutral | Get Alert |
| 05/07/2014 | MRK | Buy Now | Merck & Co | $88.28 | -27.5% | Chris Schott60% | $60 → $64 | Maintains | Overweight | Get Alert |
| 04/04/2014 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.62 | 252.11% | Chris Schott60% | $49 → $55 | Maintains | Neutral | Get Alert |
| 03/14/2014 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.62 | 213.7% | Chris Schott60% | → $49 | Upgrade | Underweight → Neutral | Get Alert |
| 11/04/2013 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.62 | 143.28% | Chris Schott60% | $43 → $38 | Downgrade | Neutral → Underweight | Get Alert |
| 09/16/2013 | BMY | Buy Now | Bristol-Myers Squibb | $59.21 | -12.18% | Chris Schott60% | $50 → $52 | Upgrade | Neutral → Overweight | Get Alert |
| 09/13/2013 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.62 | 175.29% | Chris Schott60% | $45 → $43 | Downgrade | Overweight → Neutral | Get Alert |
| 04/22/2013 | PRGO | Buy Now | Perrigo Company | $26.41 | 399.81% | Chris Schott60% | $120 → $132 | Upgrade | Neutral → Overweight | Get Alert |
| 04/03/2013 | PRGO | Buy Now | Perrigo Company | $26.41 | 354.37% | Chris Schott60% | $108 → $120 | Maintains | Neutral | Get Alert |
| 01/30/2013 | PFE | Buy Now | Pfizer | $25.24 | 22.82% | Chris Schott60% | $29 → $31 | Maintains | Overweight | Get Alert |
| 12/27/2012 | ENDP | Buy Now | Endo International | — | — | Chris Schott60% | $38 → $35 | Maintains | Overweight | Get Alert |
| 12/13/2012 | PFE | Buy Now | Pfizer | $25.24 | 14.9% | Chris Schott60% | $28 → $29 | Maintains | Overweight | Get Alert |
| 10/15/2012 | PRGO | Buy Now | Perrigo | $26.41 | 308.94% | Chris Schott60% | $102 → $108 | Maintains | Neutral | Get Alert |
| 10/05/2012 | ENDP | Buy Now | Endo International | — | — | Chris Schott60% | $45 → $42 | Maintains | Overweight | Get Alert |
| 06/04/2012 | BMY | Buy Now | Bristol-Myers Squibb | $59.21 | -40.89% | Chris Schott60% | $33 → $35 | Maintains | Neutral | Get Alert |
| 03/02/2012 | LLY | Buy Now | Eli Lilly & | $826.50 | -95.16% | Chris Schott60% | → $40 | Upgrade | Underweight → Neutral | Get Alert |
